BBIA Co., Ltd. (KOSDAQ:451250)
South Korea · Delayed Price · Currency is KRW 11,480
+700 (6.49%)
At close: Aug 6, 2025, 3:30 PM KST
Marinus Pharmaceuticals Revenue
BBIA Co., Ltd. had revenue of 15.46B KRW in the quarter ending March 31, 2025, with 24.91% growth. This brings the company's revenue in the last twelve months to 60.73B, up 46.84% year-over-year. In the year 2024, BBIA Co., Ltd. had annual revenue of 57.64B with 50.61% growth.
Revenue (ttm)
60.73B
Revenue Growth
+46.84%
P/S Ratio
1.82
Revenue / Employee
583.92M
Employees
104
Market Cap
110.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 57.64B | 19.37B | 50.61% |
| Dec 31, 2023 | 38.27B | 7.60B | 24.77% |
| Dec 31, 2022 | 30.68B | 10.53B | 52.29% |
| Dec 31, 2021 | 20.14B | -1.07B | -5.03% |
| Dec 31, 2019 | 21.21B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| HD Hyundai Heavy Industries | 15.32T |
| Doosan Enerbility | 15.88T |